Citation

Latest publication

If you use the Open Targets Platform in your work, please cite our latest publication:

Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

Previous publications

We have additional publications about the Open Targets Platform:

• Ochoa, D. et al. (2023). The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. Nucleic Acids Research.

• Ochoa, D. et al. (2021). Open Targets Platform: supporting systematic drug–target identification and prioritisation. Nucleic Acids Research.

• Carvalho-Silva, D. et al. (2019). Open Targets Platform: new developments and updates two years on. Nucleic Acids Research.

• Koscielny, G. et al. (2017). Open Targets: a platform for therapeutic target identification and validation. Nucleic Acids Research.

You can also refer to our publications about Open Targets Genetics and our Locus-to-Gene (L2G) pipeline:

• Ghoussaini, M., et al. (2021) Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Research.

• Mountjoy, E., et al. (2021) An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nature Genetics.